|
1
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang C and Freter C: Lipid metabolism,
apoptosis and cancer therapy. Int J Mol Sci. 16:924–949. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Currie E, Schulze A, Zechner R, Walther TC
and Farese RV Jr: Cellular fatty acid metabolism and cancer. Cell
Metab. 18:153–161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carracedo A, Cantley LC and Pandolfi PP:
Cancer metabolism: Fatty acid oxidation in the limelight. Nat Rev
Cancer. 13:227–232. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tafani M, Sansone L, Limana F, Arcangeli
T, De Santis E, Polese M, Fini M and Russo MA: The interplay of
reactive oxygen species, hypoxia, inflammation, and sirtuins in
cancer initiation and progression. Oxid Med Cell Longev.
2016:39071472016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim J, Kim J and Bae JS: ROS homeostasis
and metabolism: A critical liaison for cancer therapy. Exp Mol Med.
48:e2692016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reitman ZJ and Yan H: Isocitrate
dehydrogenase 1 and 2 mutations in cancer: Alterations at a
crossroads of cellular metabolism. J Natl Cancer Inst. 102:932–941.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hirata M, Sasaki M, Cairns RA, Inoue S,
Puviindran V, Li WY, Snow BE, Jones LD, Wei Q, Sato S, et al:
Mutant IDH is sufficient to initiate enchondromatosis in mice. Proc
Natl Acad Sci USA. 112:2829–2834. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sasaki M, Knobbe CB, Munger JC, Lind EF,
Brenner D, Brüstle A, Harris IS, Holmes R, Wakeham A, Haight J, et
al: IDH1(R132H) mutation increases murine haematopoietic
progenitors and alters epigenetics. Nature. 488:656–659. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cairns RA, Iqbal J, Lemonnier F, Kucuk C,
de Leval L, Jais JP, Parrens M, Martin A, Xerri L, Brousset P, et
al: IDH2 mutations are frequent in angioimmunoblastic T-cell
lymphoma. Blood. 119:1901–1903. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu X, Zhao J, Xu Z, Peng B, Huang Q,
Arnold E and Ding J: Structures of human cytosolic NADP-dependent
isocitrate dehydrogenase reveal a novel self-regulatory mechanism
of activity. J Biol Chem. 279:33946–33957. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ye J, Gu Y, Zhang F, Zhao Y, Yuan Y, Hao
Z, Sheng Y, Li WY, Wakeham A, Cairns RA and Mak TW: IDH1 deficiency
attenuates gluconeogenesis in mouse liver by impairing amino acid
utilization. Proc Natl Acad Sci USA. 114:292–297. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cohen AL, Holmen SL and Colman H: IDH1 and
IDH2 mutations in gliomas. Curr Neurol Neurosci Rep. 13:3452013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma S, Jiang B, Deng W, Gu ZK, Wu FZ, Li T,
Xia Y, Yang H, Ye D, Xiong Y and Guan KL: D-2-hydroxyglutarate is
essential for maintaining oncogenic property of mutant
IDH-containing cancer cells but dispensable for cell growth.
Oncotarget. 6:8606–8620. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lazarow PB: The role of peroxisomes in
mammalian cellular metabolism. J Inherit Metab Dis. 10 (Suppl
1):S11–S22. 1987. View Article : Google Scholar
|
|
16
|
Shechter I, Dai P, Huo L and Guan G: IDH1
gene transcription is sterol regulated and activated by SREBP-1a
and SREBP-2 in human hepatoma HepG2 cells: Evidence that IDH1 may
regulate lipogenesis in hepatic cells. J Lipid Res. 44:2169–2180.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bogdanovic E: IDH1, lipid metabolism and
cancer: Shedding new light on old ideas. Biochim Biophys Acta.
1850:1781–1785. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li F, He X, Ye D, Lin Y, Yu H, Yao C,
Huang L, Zhang J, Wang F, Xu S, et al: NADP(+)-IDH mutations
promote hypersuccinylation that impairs mitochondria respiration
and induces apoptosis resistance. Mol Cell. 60:661–675. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin G, Reitman ZJ, Duncan CG, Spasojevic
I, Gooden DM, Rasheed BA, Yang R, Lopez GY, He Y, McLendon RE, et
al: Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate
production in IDH1-mutated gliomas. Cancer Res. 73:496–501. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fu X, Chin RM, Vergnes L, Hwang H, Deng G,
Xing Y, Pai MY, Li S, Ta L, Fazlollahi F, et al: 2-hydroxyglutarate
inhibits ATP synthase and mTOR signaling. Cell Metab. 22:508–515.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gutiérrez AM, Reboredo GR and Catalá A:
Fatty acid profiles and lipid peroxidation of microsomes and
mitochondria from liver, heart and brain of Cairina moschata. Int J
Biochem Cell Biol. 34:605–612. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rohn TT, Nelson LK, Waeg G and Quinn MT:
U-101033E (2,4-diaminopyrrolopyrimidine), a potent inhibitor of
membrane lipid peroxidation as assessed by the production of
4-hydroxynonenal, malondialdehyde, and 4-hydroxynonenal-protein
adducts. Biochem Pharmacol. 56:1371–1379. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nguyen P, Leray V, Diez M, Serisier S, Le
Bloc'h J, Siliart B and Dumon H: Liver lipid metabolism. J Anim
Physiol Anim Nutr (Berl). 92:272–283. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sabharwal SS and Schumacker PT:
Mitochondrial ROS in cancer: Initiators, amplifiers or an Achilles'
heel? Nat Rev Cancer. 14:709–721. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Glasauer A and Chandel NS: Targeting
antioxidants for cancer therapy. Biochem Pharmacol. 92:90–101.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu MS, Lien GS, Shen SC, Yang LY and Chen
YC: N-acetyl-L-cysteine enhances fisetin-induced cytotoxicity via
induction of ROS-independent apoptosis in human colonic cancer
cells. Molecular Carcinogenesis. 53 (Suppl 1):E119–E129. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pelicano H, Carney D and Huang P: ROS
stress in cancer cells and therapeutic implications. Drug Resist
Updat. 7:97–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Itsumi M, Inoue S, Elia AJ, Murakami K,
Sasaki M, Lind EF, Brenner D, Harris IS, Chio II, Afzal S, et al:
Idh1 protects murine hepatocytes from endotoxin-induced oxidative
stress by regulating the intracellular NADP(+)/NADPH ratio. Cell
Death Differ. 22:1837–1845. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi J, Zuo H, Ni L, Xia L, Zhao L, Gong M,
Nie D, Gong P, Cui D, Shi W and Chen J: An IDH1 mutation inhibits
growth of glioma cells via GSH depletion and ROS generation. Neurol
Sci. 35:839–845. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin H, Patel S, Affleck VS, Wilson I,
Turnbull DM, Joshi AR, Maxwell R and Stoll EA: Fatty acid oxidation
is required for the respiration and proliferation of malignant
glioma cells. Neuro Oncol. 19:43–54. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Staiger H, Staiger K, Stefan N, Wahl HG,
Machicao F, Kellerer M and Häring HU: Palmitate-induced
interleukin-6 expression in human coronary artery endothelial
cells. Diabetes. 53:3209–3216. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Palomer X, Pizarro-Delgado J, Barroso E
and Vázquez-Carrera M: Palmitic and oleic acid: The Yin and Yang of
fatty acids in type 2 diabetes mellitus. Trends Endocrinol Metab.
29:178–190. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Leamy AK, Egnatchik RA, Shiota M, Ivanova
PT, Myers DS, Brown HA and Young JD: Enhanced synthesis of
saturated phospholipids is associated with ER stress and
lipotoxicity in palmitate treated hepatic cells. J Lipid Res.
55:1478–1488. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moravcová A, Červinková Z, Kučera O,
Mezera V, Rychtrmoc D and Lotková H: The effect of oleic and
palmitic acid on induction of steatosis and cytotoxicity on rat
hepatocytes in primary culture. Physiol Res. 64 (Suppl
5):S627–S636. 2015.PubMed/NCBI
|
|
36
|
Tirado-Vélez JM, Joumady I, Sáez-Benito A,
Cózar-Castellano I and Perdomo G: Inhibition of fatty acid
metabolism reduces human myeloma cells proliferation. PLoS One.
7:e464842012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Handy DE and Loscalzo J: Redox regulation
of mitochondrial function. Antioxid Redox Signal. 16:1323–1367.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Quinlan CL, Treberg JR, Perevoshchikova
IV, Orr AL and Brand MD: Native rates of superoxide production from
multiple sites in isolated mitochondria measured using endogenous
reporters. Free Radic Biol Med. 53:1807–1817. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fritz R, Bol J, Hebling U, Angermüller S,
Völkl A, Fahimi HD and Mueller S: Compartment-dependent management
of H(2)O(2) by peroxisomes. Free Radic Biol Med. 42:1119–1129.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zangar RC, Davydov DR and Verma S:
Mechanisms that regulate production of reactive oxygen species by
cytochrome P450. Toxicol Appl Pharmacol. 199:316–331. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Caro AA and Cederbaum AI: Role of
cytochrome P450 in phospholipase A2- and arachidonic acid-mediated
cytotoxicity. Free Radic Biol Med. 40:364–375. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
McGarry JD and Brown NF: The mitochondrial
carnitine palmitoyltransferase system. From concept to molecular
analysis. Eur J Biochem. 244:1–14. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Palomer X, Salvadó L, Barroso E and
Vázquez-Carrera M: An overview of the crosstalk between
inflammatory processes and metabolic dysregulation during diabetic
cardiomyopathy. Int J Cardiol. 168:3160–3172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Olson AL and Pessin JE: Structure,
function, and regulation of the mammalian facilitative glucose
transporter gene family. Annu Rev Nutr. 16:235–256. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Young RM and Simon MC: Untuning the tumor
metabolic machine: HIFα: Pro-and anti-tumorigenic? Nat Med.
18:1024–1025. 2012. View Article : Google Scholar : PubMed/NCBI
|
